`
`2/26/2018
`
`Proprietary Name
`Mkt.Status Active Ingredient
`PATANASE
`RX
`OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE
`PATANOL
`RX
`OLOPATADINE HYDROCHLORIDE
`PATADAY
`RX
`OLOPATADINE HYDROCHLORIDE
`PAZEO
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`RX
`OLOPATADINE HYDROCHLORIDE OLOPATADINE HYDROCHLORIDE
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`TE Code RLD RS Applicant Holder
`Appl No
`Product Number Dosage Form
`Route
`Strength
`N021861 001
`SPRAY, METERED
`NASAL
`0.665MG/SPRAY AB
`RLD RS NOVARTIS PHARMACEUTICALS CORP
`A091572 001
`SPRAY, METERED
`NASAL
`0.665MG/SPRAY AB
`APOTEX INC
`A202853 001
`SPRAY, METERED
`NASAL
`0.665MG/SPRAY AB
`PERRIGO ISRAEL PHARMACEUTICALS LTD
`N020688 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`AT
`RLD RS NOVARTIS PHARMACEUTICALS CORP
`N021545 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.2% BASE
`AT
`RLD RS NOVARTIS PHARMACEUTICALS CORP
`N206276 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.7% BASE
`RLD RS NOVARTIS PHARMACEUTICALS CORP
`A090848 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.2% BASE
`BARR LABORATORIES INC
`A078350 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`APOTEX INC
`A206306 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`SOMERSET THERAPEUTICS LLC
`A203152 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`USV NORTH AMERICA INC
`A204706 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`ZAMBON SPA
`A204812 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`AUROBINDO PHARMA LTD
`A204532 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`AKORN INC
`A200810 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`WOCKHARDT LTD
`A206046 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.1% BASE
`CIPLA LTD
`A204723 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.2% BASE
`AKORN INC
`A090918 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.2% BASE
`APOTEX INC
`A206087 001
`SOLUTION/DROPS OPHTHALMIC EQ 0.2% BASE
`CIPLA LTD
`
`AT
`AT
`AT
`AT
`AT
`AT
`AT
`AT
`AT
`AT
`AT
`AT
`
`Approval Date
`Apr 15, 2008
`Oct 8, 2014
`Jan 31, 2017
`Dec 18, 1996
`Dec 22, 2004
`Jan 30, 2015
`Jul 13, 2015
`Dec 7, 2015
`Dec 7, 2015
`Dec 7, 2015
`Dec 7, 2015
`Dec 18, 2015
`Jan 10, 2017
`Jun 28, 2017
`Jul 26, 2017
`Dec 5, 2017
`Dec 5, 2017
`Dec 5, 2017
`
`https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm
`
`Exhibit 1114
`IPR2017-00807
`ARGENTUM
`
`Page 1 of 1
`
`000001
`
`